| 1 |
한도/금지 |
은콜로이드
|
Colloidal Silver |
7440-57-5 [1], 1360157-34-1 [2], —[3] |
|
| 2 |
금지 |
트라이플루미졸
|
Triflumizole |
68694-11-1 |
(1E)-N-[4-chloro-2-(trifluoromethyl)phenyl]-1- (1H-imidazol-1-yl)-2- propoxyethanimine |
| 3 |
금지 |
인체 세포․ 조직 및 그 배양액
|
Cells, tissues or Conditioned media of human origin |
|
|
| 4 |
한도 |
하이드로제네이티드탈로우알코늄클로라이드
|
Hydrogenated Tallowalkonium Chloride |
71011-24-0 |
|
| 5 |
금지 |
디이에이-라우라미노프로피오네이트
|
DEA-Lauraminopropionate |
65104-36-1 |
|
| 6 |
금지 |
부타디엔 0.1%를 초과하여 함유하는 석유 유래물질 (Gases (petroleum), deisobutanizer tower overheads)
|
Gases (petroleum), deisobutanizer tower overheads, if they contain > 0.1% w/w Butadiene |
68477-87-2 |
|
| 7 |
금지 |
디메칠설폭사이드(DMSO)로 추출한 성분을 3% 초과하여 함유하는 석유 유래물질 (Residual oils (petroleum), clay-treated)
|
Residual oils (petroleum), clay-treated, if they contain > 3 % w/w DMSO extract |
64742-41-2 |
|
| 8 |
금지 |
N-5-클로로벤즈옥사졸-2-일아세트아미이드
|
N-(5-Chlorobenzoxazol-2-yl)acetamide |
35783-57-4 |
|
| 9 |
금지 |
플로쿠마펜 (ISO); cis-4-하이드록시-3-(1,2,3,4-테트라하이드로-3-(4-(4-트라이플루오로메틸벤질옥시)페닐)-1-나프틸)쿠마린 및 trans-4-하이드록시-3-(1,2,3,4-테트라하이드로-3-(4-(4-트라이플루오로메틸벤질옥시)페닐)-1-나프틸)쿠마린의 반응물
|
Flocoumafen (ISO); reaction mass of: cis-4- hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin and trans-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin |
90035-08-8 |
|
| 10 |
금지 |
트라이플루오로메틸데클로로에틸프로스테놀아마이드
|
Trifluoromethyl Dechloro Ethylprostenolamide |
|
|